STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 25,355,346	$ 23,108,897
General & administrative	10,707,447	13,085,232
Total operating expenses	36,062,793	36,194,129
Operating loss	(36,062,793)	(36,194,129)
Other income (expense)	107,148	(8,213)
Gain (loss) on derivative instruments	366,791	(694,858)
Other non-operating (loss) gain	(30,793)	1,685,379
Interest expense, net	(1,081,034)	(1,149,288)
Net loss	(36,700,681)	(36,361,109)
Modification of warrants	(929,122)	(350,861)
Net loss available to common shareholders	$ (37,629,803)	$ (36,711,970)
Net loss per common share - basic	$ (0.87)	$ (0.90)
Weighted average common shares outstanding - basic	43,148,888	40,662,137
Net loss per common share - diluted	$ (0.87)	$ (0.90)
Weighted average common shares outstanding - diluted	43,148,888	40,694,248